— Know what they know.
Not Investment Advice
Also trades as: TATVA.NS (NSE) · $vol 2M

TATVA.BO BSE

Tatva Chintan Pharma Chem Limited
1W: +0.9% 1M: +9.3% 3M: +40.1% YTD: +46.0% 1Y: +63.7% 3Y: +4.9%
₹1,739.20 ($18.06)
-42.65 (-2.39%)
 
BSE · Basic Materials · Chemicals - Specialty · Tech Score Buy · Power 58 · ₹40.6B mcap · 6M float · 0.135% daily turnover
Smart Money Score
Watch 0
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap₹40.6B ($421.4M)
52W Range1022-1880.45
Volume2,590
Avg Volume8,145
Beta0.42
Dividend₹2.00
Analyst Ratings
No analyst coverage
Company Info
CEOChintan Nitinkumar Shah
Employees793
SectorBasic Materials
IndustryChemicals - Specialty
IPO Date2021-07-29
Plot No. 353
Vadodara, GU 390010
IN
91 75 7484 8533
About Tatva Chintan Pharma Chem Limited

Headquartered in Vadodara, India, and founded in 1996, Tatva Chintan Pharma Chem Limited operates as a manufacturer and trader of diverse specialty chemicals. Its extensive product portfolio encompasses structure directing agents crucial for zeolite synthesis, phase transfer catalysts, and electrolyte salts utilized in supercapacitor and zinc-ion battery technologies. Additionally, the company supplies pharmaceutical active ingredients, agrochemical formulations, and various other specialized compounds such as intermediates, disinfectants, catalysts, and solvents. Tatva Chintan serves a broad spectrum of industries, including automotive, petroleum, pharmaceuticals, agrochemicals, paints and coatings, dyes and pigments, personal care, and flavor and fragrance sectors. The company maintains a global footprint, exporting its chemical solutions to several nations, notably the United States, Singapore, the United Kingdom, China, Germany, Japan, and South Africa.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms